Vir Biotechnology VIR
$8.39 −$0.48 (-5.41%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.30 -1.05%
Open$8.77
Prev close$8.87
Day range$8.34 – $8.92
Volume3.09M
Market cap$1.56B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$22.43+167.3% vs. price
- Buy 100%
Low $17.00Now $8.39Avg $22.43High $30.00
Recent rating changes
The last 20 actions on file set price targets from $17.00 to $30.00, averaging $23.32.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Barclays | BUY | $30.00 |
| 10 Nov 2026 | Morgan Stanley | BUY | $28.00 |
| 10 Nov 2026 | Evercore | BUY | $25.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $22.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $22.00 |
| 6 Nov 2026 | BofA Securities | BUY | $17.00 |
| 5 Nov 2026 | TD Cowen | BUY | – |
| 5 Nov 2026 | Morgan Stanley | BUY | $25.00 |
| 5 Nov 2026 | Evercore | BUY | $22.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $17.00 |
| 5 Nov 2026 | Barclays | BUY | $30.00 |
| 4 Nov 2026 | H.C. Wainwright | BUY | $22.00 |
| 3 Nov 2026 | H.C. Wainwright | BUY | $22.00 |
| 19 Oct 2026 | Barclays | BUY | $30.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $22.00 |
| 14 Oct 2026 | H.C. Wainwright | BUY | $22.00 |
| 8 Oct 2026 | Barclays | BUY | $30.00 |
| 7 Oct 2026 | H.C. Wainwright | BUY | $22.00 |
| 29 Sep 2026 | Leerink Partners | BUY | $17.00 |
| 28 Sep 2026 | Needham | BUY | $18.00 |
No comments yet — be the first to weigh in on VIR.
Sign in to join the discussion.